Clinical Trial Update: A Study for the Treatment of Unresectable Stage III or Metastatic Stage IV Melanoma [Phase 2]

View source ↗

Summary

Phase 2 clinical trial update for a treatment of unresectable Stage III or metastatic Stage IV melanoma, sponsored by Astellas Pharma, with the study status lis…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Melanoma

Snippet

Sponsor: Astellas Pharma Inc | Conditions: Melanoma | Phase 2 | Status: COMPLETED